| scholarly article | Q13442814 |
| P356 | DOI | 10.1002/CHIR.20356 |
| P698 | PubMed publication ID | 17167747 |
| P2093 | author name string | Andrew J McLachlan | |
| Annette S Gross | |||
| Hongmei Xu | |||
| Katarzyna K Loboz | |||
| P2860 | cites work | Behavioral and biochemical investigations of bupropion metabolites | Q28156301 |
| Pharmacokinetic optimisation of sustained-release bupropion for smoking cessation | Q34137853 | ||
| Effects of prototypical microsomal enzyme inducers on cytochrome P450 expression in cultured human hepatocytes | Q34184221 | ||
| Comparative pharmacokinetics and pharmacodynamics of the rifamycin antibacterials | Q34296734 | ||
| Enantioselective effects of hydroxy metabolites of bupropion on behavior and on function of monoamine transporters and nicotinic receptors | Q34342464 | ||
| Synthesis and evaluation of the antidepressant activity of the enantiomers of bupropion | Q34344602 | ||
| Pharmacological significance of the species differences in bupropion metabolism | Q34685532 | ||
| Bupropion: pharmacological and clinical profile in smoking cessation. | Q35073939 | ||
| Enantiomeric determination of the phenylmorpholinol metabolite of bupropion in human plasma using coupled achiral-chiral liquid chromatography | Q36866718 | ||
| Regulation of CYP2B6 in primary human hepatocytes by prototypical inducers | Q40587140 | ||
| Single-dose pharmacokinetics of bupropion in adolescents: effects of smoking status and gender | Q43673470 | ||
| Induction of cytochrome P450 enzymes in cultured precision-cut human liver slices | Q44313267 | ||
| HPLC assay for bupropion and its major metabolites in human plasma | Q46596611 | ||
| Pharmacokinetics of bupropion and its metabolites in cigarette smokers versus nonsmokers. | Q50922300 | ||
| Pharmacokinetics of bupropion and its major basic metabolites in normal subjects after a single dose | Q69968314 | ||
| Pharmacokinetics of single- and multiple-dose bupropion in elderly patients with depression | Q71483223 | ||
| P433 | issue | 3 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | stereoselectivity | Q903429 |
| P304 | page(s) | 163-70 | |
| P577 | publication date | 2007-03-01 | |
| P1433 | published in | Chirality | Q2120255 |
| P1476 | title | Stereoselective analysis of hydroxybupropion and application to drug interaction studies | |
| P478 | volume | 19 |
| Q37810213 | Chiral Determination of Antidepressant Drugs and their Metabolites in Biological Samples |
| Q42407006 | Chiral Plasma Pharmacokinetics and Urinary Excretion of Bupropion and Metabolites in Healthy Volunteers |
| Q48027985 | Chirality and neuropsychiatric drugs: an update on stereoselective disposition and clinical pharmacokinetics of bupropion |
| Q88658051 | Common Polymorphisms of CYP2B6 Influence Stereoselective Bupropion Disposition |
| Q36796793 | Development and validation of a high-throughput stereoselective LC-MS/MS assay for bupropion, hydroxybupropion, erythrohydrobupropion, and threohydrobupropion in human plasma |
| Q37148882 | Influence of CYP2B6 genetic variants on plasma and urine concentrations of bupropion and metabolites at steady state. |
| Q37358704 | Inhibition of Cytochrome P450 2B6 Activity by Voriconazole Profiled Using Efavirenz Disposition in Healthy Volunteers |
| Q37153012 | Rifampin enhances cytochrome P450 (CYP) 2B6-mediated efavirenz 8-hydroxylation in healthy volunteers |
| Q33927695 | Sensitive, selective and rapid determination of bupropion and its major active metabolite, hydroxybupropion, in human plasma by LC-MS/MS: application to a bioequivalence study in healthy Indian subjects |
| Q36236685 | Simultaneous quantitative determination of bupropion and its three major metabolites in human umbilical cord plasma and placental tissue using high-performance liquid chromatography-tandem mass spectrometry |
| Q35376254 | Stereo-specific LC and LC-MS bioassays of antidepressants and psychotics |
| Q36737009 | Stereoselective Glucuronidation of Bupropion Metabolites In Vitro and In Vivo |
| Q41153557 | Stereoselective metabolism of bupropion by cytochrome P4502B6 (CYP2B6) and human liver microsomes |
| Q36900154 | Stereoselective method to quantify bupropion and its three major metabolites, hydroxybupropion, erythro-dihydrobupropion, and threo-dihydrobupropion using HPLC-MS/MS |
| Q51831896 | Synthesis of deuterium-labeled hydroxybupropion. |
| Q36733922 | Use of enantiomeric bupropion and hydroxybupropion to assess CYP2B6 activity in glomerular kidney diseases |
Search more.